Print view
 

Establishing a Global Vaccine-Development Fund

As the Ebola epidemic in West Africa continues, albeit at a much lower level than it reached in the spring, we still lack a vaccine that has been shown to be safe and effective.

 

Vaccine development is facing a crisis for three reasons: the complexity of the most challenging targets, which necessitates substantial investment of capital and human expertise; the diminishing numbers of vaccine manufacturers able to devote the necessary resources to research, development, and production; and the prevailing business model, which prioritizes the development of vaccines with a large market potential.

Much attention has appropriately been directed at major disease targets such as human immunodeficiency virus (HIV), tuberculosis, and malaria, for which organizations such as the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Wellcome Trust are providing considerable financial support. Similar attention has been devoted to the provision of currently licensed pediatric vaccines, which is supported by GAVI (formerly the Global Alliance for Vaccines and Immunization).

Thus, the pharmaceutical industry's enthusiasm for vaccine development has dropped well below the levels seen in the 1980s and 1990s. The ClinicalTrials.gov website shows that only a minority of trials of vaccines against new infectious disease targets are sponsored by major vaccine companies and that the total number of trials is not increasing.  

Read the full article at NEJM-website

 

Autor: Stanley A. Plotkin, M.D., Adel A.F. Mahmoud, M.D., Ph.D., and Jeremy Farrar, M.D., Ph.D. N Engl J Med 2015; 373:297-300July 23, 2015DOI: 10.1056/NEJMp   Quelle: The New England Journal of Medicine
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
Weitere News
Emerging respiratory viruses, including nCoV: methods for detection, prevention, response and control
Watch the GAP! A critical civil society perspective on the “Global Action Plan for Healthy Lives and Well-Being for All”
ESTHER Switzerland Call for Proposals 2020
Evidence-based toolkit offers solutions to improve environment, health, and reduce inequalities
Public health emergencies occurring in the WHO African Region
Catalysing Change for Gender Equality
TMW Center launches bilingual resources to advance brain development for children
Short sleep may harm bone health in older women
Human Trafficking – It Came Disguised as the Opportunity of a Lifetime
Studies Yield ‘Impressive’ Results in Fight Against Cystic Fibrosis
Study finds functional medicine model is associated with improvements in health-related QOL
NHS treating 5,000 diabetics a day as one in 10 patients now suffer with illness, figures reveal
Bangladesh’s Climate Change Victims Safeguard the Sundarbans’ Endangered Dolphins
European Health Leadership Award 2019
Wall Street can Free the World’s 40 Million Modern-Day Slaves
Financing Health Promoting Services
One person dies by suicide every 40 seconds: new UN health agency report
One person dies by suicide every 40 seconds: new UN health agency report
A ‘Cure’ for Ebola but Will it Stop the Outbreak if People Won’t Get Treatment?
The Role of Women’s Organisations in Crisis-Settings
Statement on World Day against Trafficking in Persons
Vaccine Fast Facts
CRA shortage is worsening while demand grows – a vicious circle which opens masses of job opportunities
Why Doctors Hate Their Computers
Junior hospital doctors
90–90–90 Treatment for All
Incident Management System
Incident Management System
An Economy for the 99%
European Virus Archive goes global

Newsletter Sign Up

 

Helix - Forschung & Beratung WienEuropean Health Forum GasteinAnästhesie in Entwicklungsländern e. V.Hilfswerk AustriaAlumni Club Medizinische Universität WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärzte der WeltÖsterreichische Akademie der Ärzte